Stay updated on Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.

Latest updates to the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page
- Check7 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, indicating a minor site software/version update without changing the study details.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedRevision updated to v3.5.0, replacing v3.4.3.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.4.3 was applied; no changes to the study details are evident.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now shows Revision: v3.4.2 and the previous government-funding status notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check85 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the page version updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.